Cereno Scientific moves to new office space at GoCo Health Innovation City in Gothenburg
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Company is moving to a new office space at GoCo Health Innovation City in Gothenburg in June 2024. The re-location to GoCo’s inspiring community will support the further propelling of Cereno’s pipeline and the next step of the Company’s growth journey.Cereno Scientific’s pipeline comprises late-stage Phase II drug candidate CS1, an HDAC inhibitor with epigenetic effects for the treatment of the rare disease Pulmonary